Morgan Stanley’s Alto Neuroscience ANRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $142K | Buy |
64,630
+17,823
| +38% | +$39.2K | ﹤0.01% | 5990 |
|
|
2025
Q1 | $101K | Sell |
46,807
-155,834
| -77% | -$337K | ﹤0.01% | 5998 |
|
|
2024
Q4 | $857K | Buy |
202,641
+126,480
| +166% | +$535K | ﹤0.01% | 5160 |
|
|
2024
Q3 | $871K | Buy |
76,161
+49,838
| +189% | +$570K | ﹤0.01% | 5122 |
|
|
2024
Q2 | $281K | Buy |
26,323
+13,038
| +98% | +$139K | ﹤0.01% | 5529 |
|
|
2024
Q1 | $204K | Buy |
+13,285
| New | +$204K | ﹤0.01% | 5727 |
|